🧬 Check our new paper in @CellGenomics!
NeoBridge, an ML tool, ranks neoantigens by odds of triggering immune responses. Works in pancreatic cancer, where good targets are rare — and clonal position carries prognostic info. @ufvmadrid.bsky.social #PDAC
Code open 👇
www.cell.com/cell-genomic...
